NF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model

Jennifer M., Peterson, David J., Wang, Vikram, Shettigar, Steve R., Roof, Benjamin D., Canan, Nadine, Bakkar, Jonathan, Shintaku, Jin-Mo, Gu, Sean C., Little, Nivedita M., Ratnam, Priya, Londhe, Leina, Lu, Christopher E., Gaw, Jennifer M., Petrosino, Sandya, Liyanarachchi, Huating, Wang, Paul M. L., Janssen, Jonathan P., Davis, Mark T., Ziolo, Sudarshana M., Sharma, Denis C., Guttridge

Nature Communications |

Duchenne muscular dystrophy (DMD) is a neuromuscular disorder causing progressive muscle degeneration. Although cardiomyopathy is a leading mortality cause in DMD patients, the mechanisms underlying heart failure are not well understood. Previously, we showed that NF-κB exacerbates DMD skeletal muscle pathology by promoting inflammation and impairing new muscle growth. Here, we show that NF-κB is activated in murine dystrophic (mdx) hearts, and that cardiomyocyte ablation of NF-κB rescues cardiac function. This physiological improvement is associated with a signature of upregulated calcium genes, coinciding with global enrichment of permissive H3K27 acetylation chromatin marks and depletion of the transcriptional repressors CCCTC-binding factor, SIN3 transcription regulator family member A, and histone deacetylase 1. In this respect, in DMD hearts, NF-κB acts differently from its established role as a transcriptional activator, instead promoting global changes in the chromatin landscape to regulate calcium genes and cardiac function.